IL1R2 and rheumatoid arthritis: The number of type 2 decoy receptors on B lymphocytes is reduced in RA patients in the acute phase, but it is compensated for by the higher percentage of IL-1R2+  В cells in patients who had a clinical response to treatment as compared to with healthy individuals.